|
Quotes & Info
|
| APPY > SEC Filings for APPY > Form 8-K on 21-Dec-2012 | All Recent SEC Filings |
21-Dec-2012
Other Events, Financial Statements and Exhibits
On December 21, 2012, Venaxis, Inc., (formerly AspenBio Pharma, Inc.) (the "Company") issued a press release titled - "Venaxis Files for CE Mark and Prepares for European Commercialization." The press release is filed as Exhibit 99.1 to this Form 8-K.
(d) Exhibits.
Exhibits
99.1 Press Release of Venaxis, Inc. titled "Venaxis Files for CE Mark and Prepares for European Commercialization," issued December 21, 2012.
|
|